Publication | Closed Access

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

Hematological MalignancyTumor BiologyLymphoid NeoplasiaMedicineIndependent PredictorHematologyPathologyLymphatic DiseaseCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentCancer ResearchHealth Sciences